WALTHAM, Mass., Jan. 06, 2025 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced the commercial launch of ...
Repligen Corporation announced the launch of its CTech™ SoloVPE® PLUS System, an advanced UV-based Variable Pathlength Technology designed for biopharmaceutical manufacturers. This system enhances ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback